WG-PLM survey: Is Laboratory Medicine ready to the era of Personalized Medicine?

This questionnaire has been prepared by the Joint WG-PLM of EFLM and ESPT.
For comments please contact Mario Pazzagli (chair of the WG-PLM) at mario.pazzagli@unifi.it

Question Title

1. Which country do you reside:

Question Title

2. If there is the need to implement a new healthcare policy in your Hospital, who influences the decision making process? You can choose multiple options.

Government

Health Technology Assessment (HTA)

Patient Organizations

European and National Professional Societies (by Guidelines)

University Medical Centers

Doctors/Scientists

Other

Comments

Question Title

3. Can you briefly describe the activities performed in your Laboratory, if any, that can be related to Personalized Medicine (i.e. kind and number of molecular assays in genetics, cancer, pharmacogenomics, etc.)

Question Title

4. Have you read the EC Commission document cited in the invitation letter (see the link: http://ec.europa.eu/health/files/latest_news/2013-10_personalised_medicine_en.pdf)

Yes

Question Title

1. Which country do you reside:

Question Title

2. If there is the need to implement a new healthcare policy in your Hospital, who influences the decision making process? You can choose multiple options.

Question Title

3. Can you briefly describe the activities performed in your Laboratory, if any, that can be related to Personalized Medicine (i.e. kind and number of molecular assays in genetics, cancer, pharmacogenomics, etc.)

Question Title

4. Have you read the EC Commission document cited in the invitation letter (see the link: http://ec.europa.eu/health/files/latest_news/2013-10_personalised_medicine_en.pdf)

Question Title

5. If yes, can you briefly comment its value for you?